Refine
Has Fulltext
- yes (9)
Is part of the Bibliography
- yes (9)
Document Type
- Journal article (6)
- Doctoral Thesis (3)
Keywords
- glioblastoma multiforme (3)
- recurrence (3)
- MPS1 (2)
- TTK (2)
- astrocytoma (2)
- cardiac magnetic resonance imaging (2)
- low-grade glioma (2)
- mRNA (2)
- myocardial infarction (2)
- protein (2)
- ATF5 (1)
- Autoantikörper (1)
- BRMS1 (1)
- Basischarakteristika (1)
- Beta-1-Rezeptor (1)
- Chaetomium thermophilum (1)
- DNA-Reparatur (1)
- ETiCS (1)
- GFAP (1)
- General Transcription Factor II H (1)
- Genexpression (1)
- Herzinfarkt (1)
- KiSS1 (1)
- LGA (1)
- Low grade Astrocytoma (1)
- MRI (1)
- Myokardinfarkt (1)
- Myokarditis (1)
- NfL (1)
- RPS27 (1)
- ST-elevation myocardial infarction (1)
- STEMI (1)
- Ssl1 (1)
- TFIIH (1)
- Tfb4 (1)
- Transkription (1)
- Transkriptionsfaktor (1)
- behavior (1)
- blood coagulation factor XIII (1)
- brain (1)
- expression (1)
- glial damage (1)
- glial fibrillary acidic protein (1)
- glioblastoma (1)
- growth pattern (1)
- healing and remodelling processes (1)
- infarction size (1)
- mRNA expression (1)
- metastasis (1)
- multifocal growth (1)
- neurofilament light chain (1)
- p34 (1)
- p44 (1)
- protein and mRNA expression (1)
- relapse (1)
- suppressor (1)
- therapy (1)
Institute
- Pathologisches Institut (5)
- Neurochirurgische Klinik und Poliklinik (4)
- Medizinische Klinik und Poliklinik I (3)
- Deutsches Zentrum für Herzinsuffizienz (DZHI) (2)
- Institut für diagnostische und interventionelle Radiologie (Institut für Röntgendiagnostik) (2)
- Neurologische Klinik und Poliklinik (2)
- Graduate School of Life Sciences (1)
- Institut für Informatik (1)
- Institut für Pharmakologie und Toxikologie (1)
- Institut für Virologie und Immunbiologie (1)
Sonstige beteiligte Institutionen
The metastatic suppressor BRMS1 interacts with critical steps of the metastatic cascade in many cancer entities. As gliomas rarely metastasize, BRMS1 has mainly been neglected in glioma research. However, its interaction partners, such as NFκB, VEGF, or MMPs, are old acquaintances in neurooncology. The steps regulated by BRMS1, such as invasion, migration, and apoptosis, are commonly dysregulated in gliomas. Therefore, BRMS1 shows potential as a regulator of glioma behavior. By bioinformatic analysis, in addition to our cohort of 118 specimens, we determined BRMS1 mRNA and protein expression as well as its correlation with the clinical course in astrocytomas IDH mutant, CNS WHO grade 2/3, and glioblastoma IDH wild-type, CNS WHO grade 4. Interestingly, we found BRMS1 protein expression to be significantly decreased in the aforementioned gliomas, while BRMS1 mRNA appeared to be overexpressed throughout. This dysregulation was independent of patients’ characteristics or survival. The protein and mRNA expression differences cannot be finally explained at this stage. However, they suggest a post-transcriptional dysregulation that has been previously described in other cancer entities. Our analyses present the first data on BRMS1 expression in gliomas that can provide a starting point for further investigations.